Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -278.88x is 12% below its 5-year average of -248.89x, near the low end of its 5-year range (-1237.79x–9948.06x).
115.69% below its 12-month average of 1776.93x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -331.33x.
INTEREST COVERAGE RATIO
-278.88x
INTEREST COVERAGE RATIO AVG TTM
1776.93x
INTEREST COVERAGE RATIO AVG 3Y
-449.50x
INTEREST COVERAGE RATIO AVG 5Y
-248.89x
INTEREST COVERAGE RATIO AVG 10Y
-216.11x
INTEREST COVERAGE RATIO AVG 15Y
-205.86x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-115.69%
CURRENT VS 3Y AVG
+37.96%
CURRENT VS 5Y AVG
-12.05%
CURRENT VS 10Y AVG
-29.05%
CURRENT VS 15Y AVG
-35.47%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-2.97x
median of 292 covered companies
CURRENT VS SECTOR MEDIAN
-9274.12%
vs the sector median at left
Arbutus Biopharma Corp
Market Cap
$922.50M
Interest Coverage Ratio
-278.88x
TTM Avg
1776.93x
3Y Avg
-449.50x
5Y Avg
-248.89x
Market Cap
$921.45M
Interest Coverage Ratio
N/A
TTM Avg
204.36x
3Y Avg
142.82x
5Y Avg
142.82x
Market Cap
$915.95M
Interest Coverage Ratio
2.21x
TTM Avg
2.21x
3Y Avg
2.21x
5Y Avg
5.08x
Market Cap
$903.13M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$943.26M
Interest Coverage Ratio
-30.90x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$867.60M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$985.79M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$989.05M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $922.50M | -278.88x | 1776.93x | -449.50x | -248.89x |
| HealthStream, Inc. (HSTM)vs › | $921.45M | N/A | 204.36x | 142.82x | 142.82x |
| Bioventus Inc. (BVS)vs › | $915.95M | 2.21x | 2.21x | 2.21x | 5.08x |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $903.13M | N/A | N/A | N/A | N/A |
| CeriBell, Inc. (CBLL)vs › | $943.26M | -30.90x | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $867.60M | N/A | N/A | N/A | N/A |
| Apnimed, Inc. (APMD)vs › | $866.15M | N/A | N/A | N/A | N/A |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $985.79M | N/A | N/A | N/A | N/A |
| Aktis Oncology, Inc. (AKTS)vs › | $989.05M | N/A | N/A | N/A | N/A |
| Beta Bionics, Inc. (BBNX)vs › | $852.55M | N/A | N/A | N/A | N/A |
Interest Coverage
-278.9x
Debt/Equity
0.01
Current Ratio
81.42
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -331.33x |
| 2026-03-31 | 9948.06x |
| 2025-12-31 | -424.67x |
| 2025-09-30 | -360.57x |
| 2025-06-30 | 53.14x |
| 2025-03-31 | -1237.79x |
| 2024-12-31 | -464.43x |
| 2024-09-30 | -739.31x |
| 2024-06-30 | -634.79x |
| 2024-03-31 | -440.07x |
| 2023-12-31 | -471.52x |
| 2023-09-30 | -468.65x |
| 2023-06-30 | -107.51x |
| 2023-03-31 | -87.94x |
| 2022-12-31 | -73.02x |
| 2022-09-30 | -41.52x |
| 2022-06-30 | -29.27x |
| 2022-03-31 | -21.69x |
| 2021-12-31 | -37.14x |
| 2021-09-30 | -24.16x |
| 2021-06-30 | -24.43x |
| 2021-03-31 | -20.31x |
| 2020-12-31 | -20.45x |
| 2020-09-30 | -14.17x |
| 2020-06-30 | -11.96x |
| 2020-03-31 | -12.63x |
| 2019-12-31 | -13.11x |
| 2019-09-30 | -83.09x |
| 2019-06-30 | -10257.50x |
| 2019-03-31 | -1589.25x |
| 2018-12-31 | -138.55x |
| 2018-03-31 | -176.97x |
| 2017-12-31 | -803.32x |
| 2017-09-30 | -169.70x |
| 2017-06-30 | -286.54x |
| 2017-03-31 | -435.69x |
| 2013-09-30 | -28.30x |
| 2013-06-30 | -21.10x |
| 2013-03-31 | -20.71x |
| 2012-12-31 | -522.68x |
| 2012-03-31 | -108.82x |
